Business Development Director
Delta & Pharo Group
مجموع سنوات الخبرة :1 years, 3 أشهر
Define portfolio synergies that ensue both top and bottom line
Driving continuous portfolio planning process starting from screening of all opportunities based on attractiveness/accessibility model customized by therapeutic category to prioritize the new product initiatives (either first to market generics or value - added combinations or line extensions) Combine the corporate strategy, medical affairs, patient safety, compliance, in-house portfolio strategy and in-licensing business development to further strengthen SAJA brand equity with value added medicines, community collaborations, building trust with society & strategic alliances